U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06810739) titled 'The Women's Screening and Self-Testing Program (PROMETA) Study' on Jan. 28.
Brief Summary: This proposal directly addresses the ability to safely scale-up a Screen-Triage-Treat approach to cervical cancer screening. The investigators propose to capitalize on a pool of screen-eligible women accessing routine care within targeted human immunodeficiency virus (HIV) care and treatment services. The primary outcome of interest is the number of women screened and the proportion of screen-positive women undergoing treatment. Secondary outcomes will focus on other implementation outcomes, and if successful, will be utilized to inform future ...